Dietary phytoestrogens

Annual Review of Nutrition

Volumn 17, Issue , 1997, Pages 353-381

  Kurzer, Mindy S ^a   Xu, Xia ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Coumestan; Diet; Isoflavone; Lignan

Indexed keywords

ISOFLAVONE; LIGNAN; PHYTOESTROGEN;

ALFALFA; ANGIOGENESIS; ANTIOXIDANT ACTIVITY; CALORIC INTAKE; DIETARY INTAKE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FOOD INTAKE; HEART DISEASE; HUMAN; MENOPAUSE; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SOYBEAN;

ANIMALS; DIET; ESTROGENS, NON-STEROIDAL; HEALTH PROMOTION; HUMANS; ISOFLAVONES; PHYTOESTROGENS; PLANT PREPARATIONS; PLANTS, EDIBLE;

ANIMALIA; GLYCINE MAX; MEDICAGO SATIVA; TRIFOLIUM;

EID: 0030811507     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.17.1.353     Document Type: Review

References (151)

1. Adlercreutz H, Bannwart C, Wähälä K, Mäkelä T, Brunow G, et al. 1993. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J. Steroid Biochem. Molec. Biol. 44:147-53
2. Adlercreutz H, Fotsis T, Bannwart C, Wähälä K, Brunow G, et al. 1991. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, including identification of genistein. Clin. Chim. Acta 199:263-78
3. Adlercreutz H, Fotsis T, Kurzer MS, Wähälä K, Mäkelä T, et al. 1995. Isotope dilution gas chromatographic-mass spectrometric method for the determination of unconjugated lignans and isoflavonoids in human feces, with preliminary results in omnivorous and vegetarian women. Anal. Biochem. 225:101-8
4. Adlercreutz H, Fotsis T, Watanabe S, Lampe J, Wähälä K, et al. 1994. Determination of lignans and isoflavonoids in plasma by isotope dilution gas chromatography-mass spectrometry. Cancer Detect. Prev. 18(4):259-71
5. Adlercreutz H, Goldin BR, Gorbach SL, Höckerstedt KAV, Watanabe S, et al. 1995. Soybean phytoestrogen intake and cancer risk. J. Nutr. 125:757-70S
6. Adlercreutz H, Gorbach S, Goldin B. 1992. Dietary phyto-oestrogens and the menopause in Japan. Lancet 339:1233
7. Adlercreutz H, Mousavi Y, Clark J, Höckersted K, Hämäläinen EK, et al. 1992. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Molec. Biol. 41:331-37
8. Adlercreutz H, Van der Wildtz J, Kinzel J, Attalla H, Wähälä K, et al. 1995. Lignan and isoflavonoid conjugates in human urine. J. Steroid Biochem. Molec. Biol. 52:97-103
9. Agnusdei D, Zacchei F, Bigazzi S, Cepollaro C, Nardi P, et al. 1989. Metabolic and clinical effects of ipriflavone in established post-menopausal osterporosis. Drugs Exp. Clin. Res. 15(2):97-104
10. Akiyama T, Ishida J, Nakagawa S, Ogaware H, Watanable S, et al. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:5592-95
11. Anderson JJ, Ambrose WW, Garner SC. 1995. Orally dosed genistein from soy and prevention of cancellous bone loss in two ovariectomized rat models. J. Nutr. 125:799S
12. Anderson JW, Johnstone BM, Cook-Newell ME. 1995. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333:276-82
13. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL. 1996. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J. Nutr. 126:43-50
14. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, et al. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr. 126:161-67
15. Aurbach GD, Marx SJ, Spiegel AM. 1992. Metabolic bone disease. In Williams Textbook of Endocrinology, ed. JD Wilson, DW Foster, 28:1477-517. Philadelphia: Saunders. 8th ed.
16. Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson A, et al. 1982. The identification of the weak oestrogen equol [7-hydroxy-3(4′-hydroxyphenyl)chroman] in human urine. Biochem. J. 201:353-57
17. Axelson M, Sjovall J, Gustafsson BE, Setchell KDR. 1982. Origin of lignans in mammals and identification of a precursor from plants. Nature 298:659-60
18. Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KDR, et al. 1995. Dietary intervention study to assess estrogenicity of dietary soy among post-menopausal women. J. Clin. Endocrinol. Metab. 80:1685-90
19. Bannwart C, Adlercreutz H, Fotsis T, Wähälä K, Hase T, et al. 1984. Identification of O-desmethylangolensin, a metabolite of daidzein, and of matairesinol, one likely plant precursor of the animal lignan enterolactone, in human urine. Finn. Chem. Lett. 4-5:120-125
20. Bannwart C, Fotsis T, Heikkinen R, Adlercreutz H. 1984. Identification of the isoflavonic phytoestrogen daidzein in human urine. Clin. Chim. Acta 136:165-72
21. Barnes S. 1995. Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 125:777-83S
22. Barnes S, Grubbs C, Setchell KD, Carlson J. 1990. Soybeans inhibit mammary tumors in models of breast cancer. Clin. Biol. Res. 347:239-53
23. Barth CA, Scholz-Ahrens KE, Pfeuffer M, Hotze A. 1990. Response of hormones and lipid metabolism to different dietary proteins. Monogr. Atheroscler. No. 16. Basel, Switzerland: Karger
24. Bennetts HW, Underwood EJ, Shier FL. 1946. A specific breeding problem of sheep on subterranean clover pastures in western Australia. Aust. Vet. J. 22:2-12
25. Benvenuti S, Tanini A, Frediani U, Bianchi S, Masi L, et al. 1991. Effects of ipriflavone and its metabolites on clonal osteoblastic cell line. J. Bone Miner. Res. 6:987-96
26. Bickoff EM, Livingston AL, Hendrickson AP, Booth AN. 1962. Relative potencies of several estrogen-like compounds found in forages. J. Agric. Food Chem. 10:410-12
27. Bierman EL, Glomset JA. 1992. Disorders of lipid metabolism. In Williams Textbook of Endocrinology, ed. JD Wilson, DW Foster, 26:1367-95. Philadelphia: Saunders. 8th ed.
28. Borriello SP, Setchell KDR, Axelson M, Lawson AM. 1985. Production and metabolism of lignans by the human faecal flora. J. Appl. Bacteriol. 58:37-43
29. Boutin JA. 1994. Minireview - Tyrosine protein kinase inhibition and cancer. Int. J. Biochem. 26:1203-26
30. Bradbury RB, White DE. 1954. Oestrogens and related substances in plants. Vitam. Horm. 12:207-33
31. Braden AWH, Hart NK, Lamberton JA. 1967. The oestrogenic activity and metabolism of certain isoflavones in sheep. Aust. J. Agric. Res. 18:335-48
32. Braden AWH, Thain RI, Shutt DA. 1971. Comparison of plasma phyto-oestrogen levels in sheep and cattle after feeding on fresh clover. Aust. J. Agric. Res. 22:663-670
33. Breslau NA, Brinkley L, Hill KD, Pak CYC. 1988. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J. Clin. Endocrinol. Metab. 66:140-46
34. Burke TR. 1992. Protein-tyrosine kinase inhibitors. Drugs Future 17:119-31
35. Campbell DR, Kurzer MS. 1993. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J. Steroid Biochem Mol. Biol. 46:381-88
36. Carroll KK. 1991. Review of clinical studies on cholesterol-lowering response to soy protein. J. Am. Diet. Assoc. 91:820-27
37. Carroll KK, Kurowska EM. 1995. Soy consumption and cholesterol reduction: review of animal and human studies. J. Nutr. 125:594-97S
38. Cassidy A, Bingham S, Setchell KDR. 1994. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr. 60:333-40
39. Cassidy A, Bingham S, Setchell KDR. 1995. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br. J. Nutr. 74:587-601
40. Champe PC, Harvey RA. 1987. DNA synthesis. In Lippincott's Illustrated Reviews: Biochemistry, ed. PC Champe, RA Harvey, pp. 357-68. Philadelphia, PA: Lippincott
41. Chang CJ, Geahlen RL. 1992. Protein-tyrosine kinase inhibition: mechanism-based discovery of anti-tumor agents. J. Nat. Prod. 55:1529-60
42. Colditz GA, Stampfer MJ, Willett WC, Hunter DJ, Manson JE, et al. 1992. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes Control 3(5):433-39
43. Constantinou A, Huberman E. 1995. Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc. Soc. Exp. Biol. Med. 208(1): 109-15
44. Constantinou A, Kiguchi K, Huberman E. 1990. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 50:2618-24
45. Coward L, Barnes NC, Setchell KDR, Barnes S. 1993. Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J. Agric. Food Chem, 41:1961-67
46. Coward L, Kirk M, Albin N, Barbes S. 1996. Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin. Chim. Acta 247:121-42
47. Ettinger B. 1988. Prevention of osteoporosis: treatment of estradiol deficiency. Obstet. Gynecol. 72:12-17S
48. Faber KA, Hughes CL Jr. 1993. Dose-response characteristics of neonatal exposure to genistein on pituitary responsiveness to gonadotropin releasing hormone and volume of the sexually dimorphic nucleus of the preoptic area (SDN-POA) in postpubertal castrated female rats. Repro. Toxicol. 7(1):35-39
49. Farmakalidis E, Hathcock JN, Murphy PA. 1985. Oestrogenic potency of genistin and dadzin in mice. Food Chem. Toxicol. 23:741-45
50. Farmakalidis E, Murphy PA. 1984. Oestrogenic response of the CD-1 mouse to the soya-bean isoflavones genistein, genistin and daidzin. Food Chem. Toxicol. 22:237-39
51. Farmakalidis E, Murphy PA. 1984. Different oestrogenic responses of ICR, B6D2F, and B6C3F1 mice given diethylstilboestrol orally. Food Chem. Toxicol. 22:681
52. Farnsworth NR, Bingel AS, Cordell GA, Crane FA, Fond HHS. 1975. Potential value of plants as sources of new antifertility agents. J. Pharmacol. Sci. 64:717-54
53. Fitzsimmons JTR, Orson NV, El-Aaaser AA. 1989. Effects of soybean and ascorbic acid on experimental carcinogenesis. Comp. Biochem. Physiol. 93A:285-90
54. Forsythe WA III. 1986. Comparison of dietary casein or soy protein effects on plasma lipids and hormone concentrations in the gerbil. J. Nutr. 116:1165-71
55. Fotsis T, Pepper M, Adlercreutz H, Flerischmann G, Hase T, et al. 1993. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA 90:2690-94
56. Franke AA, Custer LJ, Cerna CM, Narala KN. 1995. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc. Soc. Exp. Biol. Med. 208(1): 18-26
57. Granner DK. 1990. DNA organization and replication. In Harper's Biochemistry, ed. RK Murray, Granner DK, PA Mayes, VW Rodwell, pp. 366-382. East Norwalk, CT: Appleton & Lange
58. Hadley ME. 1993. Endocrinology of pregnancy, parturition, and lactation. In Endocrinology, ed. ME Hadley, pp. 505-29. Englewood Cliffs, NJ: Prentice Hall. 3rd ed.
59. Haenszel W, Kurihara M, Segi M, Lee RKC. 1972. Stomach cancer among Japanese in Hawaii. J. Natl. Cancer Inst. 49: 969-88
60. Ham JO, Chapman KM, Essex-Sorlie D, Bakhit RM, Prabhudesai M, et al. 1993. Endocrinological response to soy protein and fiber in mildly hypercholesterolemic men. Nutr. Res. 13:873-84
61. Haytowitz DB, Matthews RH. 1986. Composition of foods: legumes and legume products. In Agriculture Handbook, No. 8 series. Washington DC: Hum. Nutr. Inform. Serv., USDA
62. Hendrich S, Lee KW, Xu X, Wang HJ, Murphy PA. 1994. Defining food components as new nutrients. J. Nutr. 124:1789-92S
63. Higashi K, Ogawara H. 1992. Effects of isoflavone compounds on the activation of phospholipase C. Chem. Pharm. Bull. 40:157-60
64. Hirayama T. 1982. Relationship of soybean paste soup intake to gastric cancer risk. Nutr. Cancer. 3:223-33
65. Hu J, Liu Y, Yu Y, Zao T, Liu S, et al. 1991. Diet and cancer of the colon and rectum: a case-control study in China. Int. J. Epidemiol 20:362-67
66. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, et al. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 172:567-72
67. Huff MW, Carroll KK. 1980. Effects of dietary protein on turnover, oxidation, and absorption of cholesterol, and on steroid excretion in rabbits. J. Lipid Res. 21:546-58
68. Hunter T, Cooper JA. 1985. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:897-930
69. Hutchins AM, Slavin JL, Lampe JW. 1995. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J. Am. Diet. Assoc. 95:545-51
70. Joannou GE, Kelly GE, Reeder AY, Waring M, Nelson C. 1995. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J. Steroid Biochem. Molec. Biol. 54(3/4):167-84
71. Kalu DN, Masoro EJ, Yu BP, Hardin RR, Hollic BW. 1988. Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction. Endocrinology 122:1847-54
72. Kellis JT Jr, Vickery LE. 1984. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 225:1032-34
73. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. 1995. The variable metabolic response to dietary isoflavones in humans. Proc. Soc. Exp. Biol. Med. 208(1):40-43
74. Kelly GE, Nelson C, Waring MA, Joannou GE, Reeder AY. 1993. Metabolites of dietary (soya) isoflavones in human urine. Clin. Chim. Acta 223:9-22
75. Kiguchi K, Constantinou AL, Huberman E. 1990. Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells. Cancer Commun. 2:271-78
76. King RA, Broadbent JL, Head RJ. 1996. Absorption and excretion of the soy isoflavone genistein in rats. J. Nutr. 126:176-82
77. Knuckles BE, De Fremery D, Kohler GO. 1976. Coumestrol content of fractions obtained from wet-processing of alfafa. J. Agric. Food Chem. 24:1177-80
78. Koo LC. 1988. Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked. Nutr. Cancer. 11:155-72 .
79. Kudou S, Fleury Y, Welti D, Magnolato D, Uchida T, et al. 1991. Malonyl isoflavone glycosides in soybean seeds (Glycine max MERRILL). Agric. Biol. Chem. 55:2227-33
80. Kurzer MS, Lampe JW, Martini MC, Adlercreutz H. 1995. Fecal lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Cancer Epidemiol. Biomarkers Prev. 4:353-58
81. Lampe JW, Martini MC, Kurzer MS, Adlercreutz H, Slavin JL. 1994. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am. J. Clin. Nutr. 60:122-28
82. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, et al. 1991. Dietary effects on breast-cancer risk in Singapore. Lancet 337:1197-200
83. Lee KW, Wang HJ, Murphy PA, Hendrich S. 1995. Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver. Nutr. Cancer. 24(3):267-78
84. Levy JR, Faber KA, Ayyash L, Hughes CL Jr. 1995. The effect of prenatal exposure to the phytoestrogen genistein on sexual differentiation in rats. Proc. Soc. Exp. Biol. Med. 208(1):60-66
85. Lieberman S. 1996. Are the differences between estradiol and other estrogens, naturally occurring or synthetic, merely semantical? J. Clin. Endocrinol. Metab. 81:850
86. Lock M. 1991. Contested meanings of the menopause. Lancet 337:1270-72
87. Lu LJW, Anderson KE, Grady JJ, Nagamani M. 1995. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol. Biomarkers Prev. 5:63-70
88. Lundh T. 1995. Metabolism of estrogenic isoflavones in domestic animals. Proc. Soc. Exp. Biol. Med. 208:33-39
89. Lundh TJO, Pettersson H, Kiessling KH. 1988. Liquid Chromatographic determination of the estrogens daidzein, formononetin, coumestrol, and equol in bovine blood plasma and urine. J. Assoc. Off. Anal. Chem. 71:938-41
90. Mäkelä S, Davis VL, Tallly WC, Korkman J, Salo L, et al. 1994. Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ. Health Perspect. 102:572-78
91. Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, et al. 1989. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49:5111-17
92. Martin PM, Horwitz KB, Ryan DS, McGuire WL. 1978. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103:1860-67
93. Medlock KL, Branham WS, Sheehan DM. 1995. Effects of coumestrol and equol on the developing reproductive tract of the rat. Proc. Soc. Exp. Biol. Med. 208(1):67-71
94. Messina MJ, Persky V, Setchell KDR, Barnes S. 1994. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21:113-31
95. Millington AJ, Francis CM, McKeown NR. 1964. Wether bioassay of annual pasture legumes. Aust. J. Agric. Res. 15:527-36
96. Molteni A, Brizio-Molteni L, Persky V. 1995. In vitro hormonal effects of soybean isoflavones. J. Nutr. 125:751-56S
97. Montfort SL, Thomson MA, Czekala NM, Kasman LH, Schakleton CH, et al. 1984. Identification of a non-steroidal estrogen, equol, in the urine of pregnant macaques: correlation with steroidal estrogen excretion. J. Steroid Biochem. 20:869-76
98. Moule GR, Braden AWH, Lamond DR. 1963. The significance of oestrogens in pasture plants in relation to animal production. Animal Breed Abstr 31:139-57
99. Mousavi Y, Adlercreutz H. 1992. Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem. Molec. Biol. 41:615-19
100. Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, et al. 1995. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 21:189-95
101. Murphy PA. 1982. Phytoestrogen content of processed soybean products. Food Technol. 36:62-64
102. Nagai M, Hashimoto T, Yanagawa H, YokoyamaH, Minowa M, 1982. Relationship of diet to the incidence of esophageal and stomach cancer in Japan. Nutr. Cancer 3:257-68
103. Nagata Y, Ishiwaki N, Sugano M. 1982. Studies on the mechanism of the antihypercholesterolemia action of soy protein and soy protein-type amino acid mixtures in relation to their casein counterparts in rats. J. Nutr. 112:1614-25
104. Naim M, Gestetner B, Bondi A, Birk Y. 1976. Antioxidative and antihemolytic activity of soybean isoflavones. J. Agric. Food Chem. 24:1174-77
105. Naim M, Gestetner B, Kirson I, Birk Y, Bondi A. 1973. A new isoflavone from soya beans. Phytochemistry 12:169-70
106. Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. 1988. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Commun. 157:183-89
107. Peterson G, Barnes S. 1991. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistence gene. Biochem. Biophys. Res. Commun. 179:661-67
108. Peterson G, Barnes S. 1993. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22:335-45
109. Phipps WR, Martini MC, Lampe JW, Slavin JL, Kurzer MS. 1993. Effect of flax seed ingestion on the menstrual cycle. J. Clin. Endocrinol. Metab. 77:1215-19
110. Potter SM. 1995. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J. Nutr. 125:606-11S
111. Potter SM, Bakhit RM, Essex-Sorlie DL, Weingartner KE, Chapman KM, et al. 1993. Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am. J. Clin. Nutr. 58:501-6
112. Pratt DE, Birac PM. 1979. Source of antioxidant activity of soybeans and soy products. J. Food Sci. 44:1720-22
113. Price KR, Fenwick GR. 1985. Naturally occuring oestrogens in foods - a review. Food Addit. Contam. 2:73-106
114. Sanchez A, Hubbard RW. 1991. Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med. Hypotheses 35:324-29
115. Sartorelli AC. 1985. Malignant cell differentiation as a potential therapeutic approach. Br. J. Cancer 52:293-302
116. Scholz-Ahrens KE, Hagemeister H, Unshelm J, Agergaard N, Barth CA. 1990. Response of hormones modulating plasma cholesterol to dietary casein or soy protein in minipigs. J. Nutr. 120:1387-92
117. Serraino M, Thompson LU. 1991. The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. Cancer Lett. 60(2):135-42
118. Serraino M, Thompson LU. 1992. Flaxseed supplementation and early markers of colon carcinogenesis. Cancer Lett. 63(2):159-65
119. Setchell KDR, Adlercreutz H. 1988. Mammalian lignans and phytoestrogens. Recent studies on their formation, metabolism and biological role in health and disease. In Role of the Gut Flora in Toxicity and Cancer, ed. IR Rowland, pp. 315-45. London: Academic
120. Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. 1984. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr. 40:569-78
121. Setchell KDR, Gosselin SJ, Welsh MB, Johnston JO, Balistreri WF, et al. 1987. Dietary estrogens - a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 93:225-33
122. Setchell KDR, Lawson AM, Mitchell FL, Adlercreutz H, Kirk DN, et al. 1980. Lignans in man and in animal species. Nature 287:740-42
123. Severson RK, Nomura AMY, Grove JS, Stemmermann GN. 1989. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 49:1857-60
124. Shutt DA, Braden AWH. 1968. The significance of equol in relation to the oestrogenic responses in sheep ingesting clover with a high formononetin content. Aust. J. Agric. Res. 19:545-53
125. Shutt DA, Cox RI. 1972. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. Endocrinology 52:299-310
126. Sirtori CR, Even R, Lovati MR. 1993. Soybean protein diet and plasma cholesterol: from therapy to molecular mechanisms. Ann. NY Acad. Sci. 676:188-201
127. Stamler J. 1979. Population studies. In Nutrition and Lipids and Coronary Heart Disease, ed. RI Levy, BM Rifkind, BH Dennis, N Ernst, pp. 25-88. New York: Raven
128. Stitch SR, Toumba JK, Groen MB, Funke CW, Leemhuis J, et al. 1980. Excretion, isolation and structure of a new phenolic constituent of female urine. Nature 287:738-40
129. Stob M. 1983. Naturally occurring food toxicants: oestrogens. In Handbook of Naturally Occurring Food Toxicants, ed. M Rechcigl Jr, pp. 81-100. Boca Raton, FL: CRC
130. Swanson CA, Mao BL, Li JY, Lubin JH, Yao SX, et al. 1992. Dietary determinants of lung-cancer risk: results from a case-control study in Yunnan Province, China. Int. J. Cancer 50:876-80
131. Thompson LU, Robb P, Serraino M, Cheung F. 1991. Mammalian lignan production from various foods. Nutr. Cancer 16:43-52
132. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. 1992. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 52:6200-8
133. Tsutsumi N. 1995. Effect of coumestrol on bone metabolism in organ culture. Biol. Pharm. Bull. 18(7):1012-15
134. Van der Meer R, de Vries HT, van Tintelen G. 1988. The phosphorylation state of casein and the species-dependency of its hypercholesterolemic effect. Br. J. Nutr. 59:467-73
135. Verdeal K, Brown RR, Richardson T, Ryan DS. 1980. Affinity of phytoestrogen for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz(a) anthracene-induced rat mammary tumors. J. Natl. Cancer Inst. 64:285-90
136. Wang C, Mäkelä T, Hase T, Adlercreutz H, Kurzer MS. 1994. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J. Steroid Biochem. Molec. Biol. 50:205-12
137. Wang HJ, Murphy PA. 1994. Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 42:1666-73
138. Wang TTY, Sathyamoorthy N, Phang JM. 1996. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17(2):271-75
139. Wang W, Tanaka Y, Han Z, Higuchi CM. 1995. Proliferative response of mammary glandular tissue to formononetin. Nutr Cancer 23:131-40
140. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. 1995. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol Med. 208(1): 124-30
141. Welshons WV, Rottinghaus GE, Nonneman DJ, Dolan-Timpe M, Ross PF. 1990. A sensitive bioassay for detection of dietary estrogens in animal feeds. J. Vet. Diagn. Invest. 2:268-73
142. Whitten PL, Lewis C, Naftolin F. 1993. A phytoestrogen diet induces the premature anovulatory syndrome in lactationally exposed female rats. Biol. Reprod. 49:1117-21
143. Whitten PL, Naftolin F. 1992. Effects of a phytoestrogen diet on estrogen-dependent reproductive processes in immature female rats. Steroids 57:56-61
144. Wilcox G, Wahlqvist M, Burger H, Medley G. 1990. Oestrogenic effects of plant foods in postmenopausal women. Br. Med. J. 301:905-6
145. Wong E. 1975. The isoflavonoids. In The Flavonoids, ed. JB Harbourne, TJ Mabry, H Mabry, pp. 780-84. London: Chapman & Hall
146. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. 1995. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 125:2307-15
147. Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S. 1994. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr. 124:825-32
148. Yamazaki I, Kinoshita M. 1986. Calcitonin-secreting property of ipriflavone in the presence of estrogen. Life Sci. 38:1535-41
149. Yanagihara K, Ito A, Toge T, Numoto M. 1993. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 53:5815-21
150. You WC, Blot WJ, Chang YS, Ershow AG, Yang ZT, et al. 1988. Diet and high risk of stomach cancer in Shandong, China. Cancer Res, 48:3518-23
151. Yueh TL, Chu HY. 1977. The metabolic fate of daidzein. Sci. Sin. 20:513-22